A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemokine Receptor 2 Detection. From Flow Cytometry to the Development of Targeted Positron Emission Tomography Molecular Imaging. Pre-clinical Studies and First In-human Proof of Concept

Name: A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemokine Receptor 2 Detection. From Flow Cytometry to the Development of Targeted Positron Emission Tomography Molecular Imaging. Pre-clinical Studies and First In-human Proof of Concept
Published: 2023
License: Public Domain

Azienda Ospedaliero-Universitaria di Parma · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

fluorescence mri mrs pet

myelofibrosis (mf), c-c chemokine receptor 2, myeloproliferative neoplasms, pet, immunohystochemical assay, early detection of cancer, progression monitoring, therapy response monitoring, mri, mrs, fluorescence, interventional

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents